XML 35 R21.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders' Equity
12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Stockholders' Equity Stockholders’ Equity
The Company had authorized shares of 20,000,000 in common stock with 11,115,779 shares issued as of December 31, 2023 and 2022. The common stock has a par value of $0.01 per share and the Company did not make any dividend payments during the years ended December 31, 2023 and 2022.
As of December 31, 2023 and 2022, the Company withheld 24,886 and 27,636 shares for approximately $315 and $410, respectively, from employees to pay their withholding taxes in connection with the vesting of restricted stock awards. During the first quarter of 2023, the Company's Board of Directors authorized the repurchase of up to $15,000 of the Company's common stock in open market transactions through February 2026. Repurchases are limited to up to $5,000 in any trailing 12-month period, with unused amounts carrying forward to future periods through the end of the authorization. Any repurchases will be subject to the Company’s liquidity, including availability of borrowings and covenant compliance under its revolving credit facility, and other capital needs of the business. In connection with the stock repurchase program, 134,208 shares valued at $2,310 were repurchased during the year ended December 31, 2023 and no shares were repurchased for the year ended December 31, 2022. There were no dividends declared during the years ended December 31, 2023 and 2022.
 Common Stock
TreasuryOutstanding
(Number of Shares)
Balance at end of 2021445,436 10,670,343 
Issued for stock-based compensation plans(106,484)106,484 
Balance at end of 2022338,952 10,776,827 
Issued for stock-based compensation plans(91,316)91,316 
Repurchased common stock134,208 (134,208)
Balance at end of 2023381,844 10,733,935